Fifth Third Bancorp’s Voyager Therapeutics VYGR Stock Holding History

Fifth Third Bancorp’s Portfolio VYGR Stock Details VYGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-800	Closed	-$14K	–	2352
2019 Q3	$14K	Buy	+800	New	+$16.8K	﹤0.01%	1719

Other funds holding VYGR

TGI

TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Fifth Third Bancorp's VYGR Position: Q4 2019 in Review

Fifth Third Bancorp sold out of Voyager Therapeutics (VYGR) in Q4 2019, closing a stake of 800 shares — an estimated $14K sold.

Fifth Third Bancorp first reported a position in VYGR in Q3 2019 and held it in 1 quarter. The position peaked at $14K in Q3 2019. 138 funds tracked by Wall St. Rank hold VYGR as of Q4 2019.

Fifth Third Bancorp reported no remaining Voyager Therapeutics position as of Q4 2019 after selling out during the quarter.
Fifth Third Bancorp sold 800 Voyager Therapeutics shares in Q4 2019, an estimated $14K.
Fifth Third Bancorp first reported a position in Voyager Therapeutics in Q3 2019 and held it in 1 quarter.
Fifth Third Bancorp's Voyager Therapeutics position peaked at $14K in Q3 2019.
138 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q4 2019.

Based on Fifth Third Bancorp's 13F filing for Q4 2019, filed 14 Feb 2020.